D
Revolution Medicines, Inc. RVMD
$37.01 $0.531.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -97.16% -97.49%
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -97.16% -97.49%
Cost of Revenue 50.55% 50.92% 46.66% 67.35% 76.80%
Gross Profit -50.85% -52.81% -52.15% -86.54% -104.97%
SG&A Expenses 62.33% 52.02% 55.95% 60.54% 59.95%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 55.82% 48.40% 45.70% 59.07% 63.76%
Operating Income -56.02% -49.69% -49.35% -70.15% -78.54%
Income Before Tax -55.49% -43.15% -36.59% -69.00% -76.21%
Income Tax Expenses 78.63% 78.63% 78.63% 108.60% -739.05%
Earnings from Continuing Operations -56.40% -44.03% -37.52% -71.14% -75.27%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -56.40% -44.03% -37.52% -71.14% -75.27%
EBIT -56.02% -49.69% -49.35% -70.15% -78.54%
EBITDA -56.41% -49.94% -49.56% -70.71% -79.27%
EPS Basic -23.49% -6.30% 5.49% -10.04% -16.27%
Normalized Basic EPS -28.83% -10.76% 1.52% -3.26% -11.39%
EPS Diluted -23.49% -6.30% 5.49% -10.04% -16.27%
Normalized Diluted EPS -28.83% -10.76% 1.52% -3.26% -11.39%
Average Basic Shares Outstanding 23.62% 32.92% 48.29% 59.43% 54.51%
Average Diluted Shares Outstanding 23.62% 32.92% 48.29% 59.43% 54.51%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --